Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation
PRESS RELEASE Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation Oncology Virtual Expert Enables Semi-Automated, On-Premise Tumor Segmentation for Neuro-Oncology Teams Across North America AARHUS, DENMARK, 25…

